PMID- 35917217 OWN - NLM STAT- MEDLINE DCOM- 20221011 LR - 20221017 IS - 1522-7278 (Electronic) IS - 1520-4081 (Linking) VI - 37 IP - 11 DP - 2022 Nov TI - The upregulation of glutamate decarboxylase 67 against hippocampal excitability damage in male fetal rats by prenatal caffeine exposure. PG - 2703-2717 LID - 10.1002/tox.23630 [doi] AB - As a kind of xanthine alkaloid, caffeine is widely present in beverages, food, and analgesic drugs. Our previous studies have shown that prenatal caffeine exposure (PCE) can induce programmed hypersensitivity of the hypothalamic-pituitary-adrenal (HPA) axis in offspring rats, which is involved in developing many chronic adult diseases. The present study further examined the potential molecular mechanism and toxicity targets of hippocampal dysfunction, which might mediate the programmed hypersensitivity of the HPA axis in offspring. Pregnant rats were intragastrically administered with 0, 30, and 120 mg/kg/day caffeine from gestational days (GD) 9-20, and the fetal rats were extracted at GD20. Rat fetal hippocampal H19-7/IGF1R cell line was treated with caffeine, adenosine A2A receptor (A2AR) agonist (CGS-21680) or adenylate cyclase agonist (forskolin) plus caffeine. Compared with the control group, hippocampal neurons of male fetal rats by PCE displayed increased apoptosis and reduced synaptic plasticity, whereas glutamate decarboxylase 67 (GAD67) expression was increased. Moreover, the expression of A2AR was down-regulated, PCE inhibited the cAMP/PKA/CREB/BDNF/TrkB pathway. Furthermore, the results in vitro were consistent with the in vivo study. Both CGS21680 and forskolin could reverse the above alteration caused by caffeine. These results indicated that PCE inhibits the BDNF pathway and mediates the hippocampus's glutamate (Glu) excitotoxicity. The compensatory up-regulation of GAD67 unbalanced the Glu/gamma-aminobutyric acid (GABA)ergic output, leading to the impaired negative feedback to the hypothalamus and hypersensitivity of the HPA axis. CI - (c) 2022 Wiley Periodicals LLC. FAU - Lu, Mengxi AU - Lu M AD - Department of Pharmacology, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China. FAU - He, Xia AU - He X AD - Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan, China. FAU - Jiao, Zhexiao AU - Jiao Z AD - Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan, China. FAU - Hu, Zewen AU - Hu Z AD - Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan, China. FAU - Guo, Zijing AU - Guo Z AD - Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan, China. FAU - Dai, Shiyun AU - Dai S AD - Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan, China. FAU - Wang, Hui AU - Wang H AD - Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan, China. AD - Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China. FAU - Xu, Dan AU - Xu D AUID- ORCID: 0000-0003-4408-2469 AD - Department of Pharmacology, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China. AD - Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China. LA - eng GR - 2019ACA140/Major Technological Innovation Projects of Hubei Province/ GR - TFJC2018001/Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University/ GR - 2020YFA0803900/National Key R&D Program of China/ GR - 81973405/National Natural Science Foundation of China/ GR - 82122071/National Natural Science Foundation of China/ GR - 82030111/National Natural Science Foundation of China/ PT - Journal Article DEP - 20220802 PL - United States TA - Environ Toxicol JT - Environmental toxicology JID - 100885357 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Receptor, Adenosine A2A) RN - 1F7A44V6OU (Colforsin) RN - 3G6A5W338E (Caffeine) RN - 3KX376GY7L (Glutamic Acid) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - EC 4.1.1.15 (Glutamate Decarboxylase) RN - EC 4.1.1.15 (glutamate decarboxylase 1) RN - EC 4.6.1.1 (Adenylyl Cyclases) SB - IM MH - Adenylyl Cyclases/metabolism MH - Animals MH - Brain-Derived Neurotrophic Factor/metabolism MH - *Caffeine/toxicity MH - Colforsin/metabolism MH - Female MH - *Glutamate Decarboxylase/genetics/metabolism MH - Glutamic Acid/metabolism MH - Hippocampus/metabolism MH - Hypothalamo-Hypophyseal System/metabolism MH - Male MH - *Pituitary-Adrenal System MH - Pregnancy MH - *Prenatal Exposure Delayed Effects/metabolism MH - Rats MH - Rats, Wistar MH - Receptor, Adenosine A2A/metabolism MH - Up-Regulation MH - gamma-Aminobutyric Acid OTO - NOTNLM OT - caffeine OT - glutamate decarboxylase 67 OT - hippocampus OT - hypothalamic-pituitary-adrenal axis EDAT- 2022/08/03 06:00 MHDA- 2022/10/12 06:00 CRDT- 2022/08/02 12:42 PHST- 2022/06/25 00:00 [revised] PHST- 2022/03/25 00:00 [received] PHST- 2022/07/13 00:00 [accepted] PHST- 2022/08/03 06:00 [pubmed] PHST- 2022/10/12 06:00 [medline] PHST- 2022/08/02 12:42 [entrez] AID - 10.1002/tox.23630 [doi] PST - ppublish SO - Environ Toxicol. 2022 Nov;37(11):2703-2717. doi: 10.1002/tox.23630. Epub 2022 Aug 2.